|
Volumn 159, Issue 4, 2002, Pages 567-572
|
Racial disparities in antipsychotic prescription patterns for patients with schizophrenia
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLOZAPINE;
FLUPHENAZINE;
FLUPHENAZINE DECANOATE;
HALOPERIDOL;
HALOPERIDOL DECANOATE;
NEUROLEPTIC AGENT;
RISPERIDONE;
THIORIDAZINE;
ADULT;
ARTICLE;
CAUCASIAN;
CLINICAL TRIAL;
FEMALE;
HEALTH CARE QUALITY;
HEALTH CARE UTILIZATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEDICAID;
MENTAL HEALTH SERVICE;
NEGRO;
PRESCRIPTION;
PRIORITY JOURNAL;
RACE DIFFERENCE;
SCHIZOPHRENIA;
EMPIRICAL APPROACH;
MENTAL HEALTH THERAPIES;
PROFESSIONAL PATIENT RELATIONSHIP;
ADOLESCENT;
ADULT;
AFRICAN AMERICANS;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
CROSS-CULTURAL COMPARISON;
DELAYED-ACTION PREPARATIONS;
DRUG UTILIZATION;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
FEMALE;
HUMANS;
MALE;
MEDICAID;
MIDDLE AGED;
PREJUDICE;
PRESCRIPTIONS, DRUG;
RISPERIDONE;
SCHIZOPHRENIA;
UNITED STATES;
|
EID: 0036221318
PISSN: 0002953X
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ajp.159.4.567 Document Type: Article |
Times cited : (176)
|
References (34)
|